Orforglipron is a once-daily oral pill, structurally a non-peptide small molecule, with no food or water restrictions, producing about 12.4% weight loss at 36 mg over 72 weeks in ATTAIN-1
Our approach at TrimRx is built on the foundation of personalized, medically supervised care
The review also discussed the role of GLP-1 in the context of bariatric surgery, as well as its impact on inflammation, cardiovascular health, appetite control, and pancreatic function
To reach a higher NNH, the results of these trials will need to be taken into account
The bottom line up front: Retatrutide slows alcohol metabolism, increases blood alcohol levels, extends intoxication duration, and may amplify GI side effects